Page last updated: 2024-09-05

lenalidomide and vatalanib

lenalidomide has been researched along with vatalanib in 1 studies

Compound Research Comparison

Studies
(lenalidomide)
Trials
(lenalidomide)
Recent Studies (post-2010)
(lenalidomide)
Studies
(vatalanib)
Trials
(vatalanib)
Recent Studies (post-2010) (vatalanib)
3,5327252,8502764298

Protein Interaction Comparison

ProteinTaxonomylenalidomide (IC50)vatalanib (IC50)
Bile salt export pumpHomo sapiens (human)10
Epidermal growth factor receptorHomo sapiens (human)0.4577
Platelet-derived growth factor receptor betaHomo sapiens (human)0.2013
Mast/stem cell growth factor receptor KitHomo sapiens (human)0.73
Vascular endothelial growth factor receptor 1 Homo sapiens (human)0.1192
Vascular endothelial growth factor receptor 3Homo sapiens (human)0.1475
Vascular endothelial growth factor receptor 2Homo sapiens (human)0.378
Vascular endothelial growth factor receptor 2Danio rerio (zebrafish)0.49

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bockman, J; Rice, MC1

Other Studies

1 other study(ies) available for lenalidomide and vatalanib

ArticleYear
Anticancer Drug Discovery and Development - SRI's Seventh Annual Summit.
    IDrugs : the investigational drugs journal, 2005, Volume: 8, Issue:10

    Topics: Angiogenesis Inhibitors; Benzamides; Chemistry, Pharmaceutical; Clinical Trials as Topic; Cooperative Behavior; Diphenylamine; Drug Industry; Drugs, Investigational; Humans; Lenalidomide; Marketing; Phthalazines; Piperazines; Protein Serine-Threonine Kinases; Pyrazoles; Pyridines; Quinolines; Receptor Protein-Tyrosine Kinases; Receptor, Transforming Growth Factor-beta Type II; Receptors, Transforming Growth Factor beta; Stem Cell Factor; Thalidomide; Thiophenes; Vascular Endothelial Growth Factor A

2005